22 Mar, 2018
- Market News
- Analyst Reports
- Personal Finance
Fields with * are required.
Spark Therapeutics Inc (NASDAQ: ONCE) Luxturna, the first gene therapy in the U.S., has been approved by the Food and Drug Administration. The gene therapy is intended to treat a rare, inherited retinal disease that could possibly cause blindness. U..
While investors were pitched the multiple benefits of the $69 billion CVS Health Corp (NYSE: CVS) - Aetna Inc (NYSE: AET) merger, the former pitched to its shareholders and the general public that this merger could transform the drugstores owned by ..
Walgreens Boots Alliance Inc (NASDAQ: WBA) has received the regulatory clearance required for the acquisition of Rite Aid Corporation (NYSE: RAD) for 4.375 billion in cash. Tuesday Walgreens announced that the amended and restated asset purchase agr..
All rights reserved.